Suchergebnisse - Davis, Mat D.

Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study

von Khan, Omar, Rieckmann, Peter, Boyko, Alexey, Selmaj, Krzysztof, Ashtamker, Natalia, Davis, Mat D., Kolodny, Scott, Zivadinov, Robert

Online lesen (frei zugänglich)